Skip to main content

MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals board will consider financial results

01 Aug 2012 Evaluate
GlaxoSmithKline Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on August 13, 2012, to consider unaudited financial results for the quarter April - June 2012 (Q2) and half year January - June 2012.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1380.00
Cipla 1394.00
Lupin 1972.50
Zydus Lifesciences 1189.00
View more..